Citation Impact
Citing Papers
Immune and Stromal Classification of Colorectal Cancer Is Associated with Molecular Subtypes and Relevant for Precision Immunotherapy
2016
Cytokine release syndrome after blinatumomab treatment related to abnormal macrophage activation and ameliorated with cytokine-directed therapy
2013
Bispecific antibodies for cancer therapy
2009
De novo design of modular and tunable protein biosensors
2021 StandoutNatureNobel
Proceedings from the National Cancer Institute’s Second International Workshop on the Biology, Prevention, and Treatment of Relapse after Hematopoietic Stem Cell Transplantation: Part III. Prevention and Treatment of Relapse after Allogeneic Transplantation
2013
Hyaluronic Acid Hydrogels for Biomedical Applications
2011 Standout
Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia
2013 Standout
Oncology Meets Immunology: The Cancer-Immunity Cycle
2013 Standout
Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting
2007
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Cancer nanomedicine: progress, challenges and opportunities
2016 Standout
Toxicity management for patients receiving novel T-cell engaging therapies
2013
The CD85j+ NK Cell Subset Potently Controls HIV-1 Replication in Autologous Dendritic Cells
2008 StandoutNobel
mRNA-based therapeutics — developing a new class of drugs
2014 StandoutNobel
Host-defense peptides of the skin with therapeutic potential: From hagfish to human
2015
Strictly Target Cell-dependent Activation of T Cells by Bispecific Single-chain Antibody Constructs of the BiTE Class
2007
Cellular senescence in aging and age-related disease: from mechanisms to therapy
2015 Standout
Antibody engineering and modification technologies
2007
Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future
2017 Standout
Understanding the tumor immune microenvironment (TIME) for effective therapy
2018 Standout
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Transiently redirected T cells for adoptive transfer
2010
Engineering lymphocyte subsets: tools, trials and tribulations
2009
Isolation of rare circulating tumour cells in cancer patients by microchip technology
2007 StandoutNature
Relapsed childhood acute lymphoblastic leukaemia
2013
Gene conversion causing human inherited disease: Evidence for involvement of non-B-DNA-forming sequences and recombination-promoting motifs in DNA breakage and repair
2009
CD19-/CD3-bispecific antibody of the BiTE class is far superior to tandem diabody with respect to redirected tumor cell lysis
2006
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
2021 StandoutNobel
Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia
2011 Standout
Nitric Oxide Dysfunction in the Pathophysiology of Preeclampsia
2000
Elimination of large tumors in mice by mRNA-encoded bispecific antibodies
2017 StandoutNobel
Remodelling the extracellular matrix in development and disease
2014 Standout
Platelets in inflammation and atherogenesis
2005 Standout
Activation, coactivation, and costimulation of resting human natural killer cells
2006
Free radicals and antioxidants in normal physiological functions and human disease
2006 Standout
l -Arginine for the prevention and treatment of coronary artery disease
2001
Introduction to current and future protein therapeutics: A protein engineering perspective
2011
Coming of age: ten years of next-generation sequencing technologies
2016 Standout
Modulation of EZH2 expression in T cells improves efficacy of anti–CTLA-4 therapy
2018 StandoutNobel
Nitric oxide in the pathogenesis of vascular disease
2000
The role of L-arginine in the prevention and treatment of pre-eclampsia: a systematic review of randomised trials
2013
Characterization of the first-in-class T-cell-engaging bispecific single-chain antibody for targeted immunotherapy of solid tumors expressing the oncofetal protein claudin 6
2015
Emerging cell and cytokine targets in rheumatoid arthritis
2013
Pediatric posttransplant relapsed/refractory B-precursor acute lymphoblastic leukemia shows durable remission by therapy with the T-cell engaging bispecific antibody blinatumomab
2014
Engineered T cells for cancer therapy
2014
Soluble endoglin contributes to the pathogenesis of preeclampsia
2006 Standout
Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
2014 Standout
T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial
2014 Standout
Frequent EpCam protein expression in human carcinomas
2004
Bispecific antibodies: a mechanistic review of the pipeline
2019
Alpharetroviral self-inactivating vectors produced by a superinfection-resistant stable packaging cell line allow genetic modification of primary human T lymphocytes
2016 StandoutNobel
Gold nanoparticles in biomedical applications: recent advances and perspectives
2011 Standout
VEGF in Signaling and Disease: Beyond Discovery and Development
2019 Standout
Genome-wide genetic marker discovery and genotyping using next-generation sequencing
2011 Standout
Chimeric antigen receptor T-cell therapy — assessment and management of toxicities
2017 Standout
A sensitivity scale for targeting T cells with chimeric antigen receptors (CARs) and bispecific T-cell Engagers (BiTEs)
2012
Synthesis of Heterobifunctional Protein Fusions Using Copper‐Free Click Chemistry and the Aldehyde Tag
2012 StandoutNobel
Managing Cytokine Release Syndrome Associated With Novel T Cell-Engaging Therapies
2014
Pre-eclampsia
2015 Standout
APD3: the antimicrobial peptide database as a tool for research and education
2015 Standout
Long-Term Follow-Up of Patients With Mild Coronary Artery Disease and Endothelial Dysfunction
2000 Standout
Brown Adipose Tissue in Adult Humans: A Metabolic Renaissance
2013
Role of Endothelial Dysfunction in Atherosclerosis
2004 Standout
Engineered Proteins Pull Double Duty
2010
Acute Myeloid Leukemia
2015 Standout
Alternative molecular formats and therapeutic applications for bispecific antibodies
2015
Adoptive cell transfer as personalized immunotherapy for human cancer
2015 StandoutScience
Loss of the Protein Tyrosine Phosphatase PTPN22 Reduces Mannan-Induced Autoimmune Arthritis in SKG Mice
2016 StandoutNobel
Advances in targeted therapeutic agents
2010
Aggregation-Induced Emission: Together We Shine, United We Soar!
2015 Standout
An Evolutionary View of the Mechanism for Immune and Genome Diversity
2012 StandoutNobel
A development that may evolve into a revolution in medicine: mRNA as the basis for novel, nucleotide-based vaccines and drugs
2013
Cytokine Storm
2020 Standout
A Pictet-Spengler ligation for protein chemical modification
2012 StandoutNobel
Chimeric Antigen Receptor Therapy
2018 Standout
Modular repeat protein sculpting using rigid helical junctions
2020 StandoutNobel
Endothelial von Willebrand factor recruits platelets to atherosclerosis-prone sites in response to hypercholesterolemia
2002
Asymmetric Dimethylarginine (ADMA): A Novel Risk Factor for Endothelial Dysfunction
1998
Synthesis of Bispecific Antibodies using Genetically Encoded Unnatural Amino Acids
2012
Tutorial on Monoclonal Antibody Pharmacokinetics and Its Considerations in Early Development
2018
Targeting the nuclear antigen 1 of Epstein-Barr virus to the human endocytic receptor DEC-205 stimulates protective T-cell responses
2008 StandoutNobel
Evolutionary Comparison of the Mechanism of DNA Cleavage with Respect to Immune Diversity and Genomic Instability
2012 StandoutNobel
Engineering Approaches to Immunotherapy
2012
Tumor Immunotherapy Using Gene-Modified Human Mesenchymal Stem Cells Loaded into Synthetic Extracellular Matrix Scaffolds
2008
Modern Technologies for Creating Synthetic Antibodies for Clinical Application
2009
CAR T cell immunotherapy for human cancer
2018 StandoutScience
Photopharmacology: Beyond Proof of Principle
2014 StandoutNobel
Innate or Adaptive Immunity? The Example of Natural Killer Cells
2011 StandoutScience
Does ADMA Cause Endothelial Dysfunction?
2000
Works of Andreas Wolf being referenced
Highly efficient antigen targeting to M-DC8+ dendritic cells via FcγRIII/CD16-specific antibody conjugates
2005
MT110: A novel bispecific single-chain antibody construct with high efficacy in eradicating established tumors
2005
A gene conversion hotspot in the human growth hormone (GH1) gene promoter
2008
In vitro and in vivo activity of MT201, a fully human monoclonal antibody for pancarcinoma treatment
2002
Statistical inference of allelic imbalance from transcriptome data
2010
Association studies of the copy-number variable ß-defensin cluster on 8p23.1 in adenocarcinoma and chronic pancreatitis
2012
Technology-specific error signatures in the 1000 Genomes Project data
2011
Dietary l-Arginine Supplementation Normalizes Platelet Aggregation in Hypercholesterolemic Humans
1997
Familial influences and obesity-associated metabolic risk factors contribute to the variation in resting energy expenditure: the Kiel Obesity Prevention Study
2008
High concentrations of therapeutic IgG1 antibodies are needed to compensate for inhibition of antibody-dependent cellular cytotoxicity by excess endogenous immunoglobulin G
2005
Adhesiveness of Mononuclear Cells in Hypercholesterolemic Humans Is Normalized by Dietary l -Arginine
1997
Immunopharmacologic response of patients with B-lineage acute lymphoblastic leukemia to continuous infusion of T cell–engaging CD19/CD3-bispecific BiTE antibody blinatumomab
2012
T cell-engaging BiTE antibodies specific for EGFR potently eliminate KRAS- and BRAF-mutated colorectal cancer cells
2010
Tumor Regression in Cancer Patients by Very Low Doses of a T Cell–Engaging Antibody
2008 Science